Feasibility and safety of EUS-guided biliary drainage in inexperienced centers: a multicenter study in southwest Japan.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Koga Takehiko, Ishida Yusuke, Hashigo Shunpei, Shimokawa Yuzo, Harima Hirofumi, Okamoto Kazuhisa, Ohno Akihisa, Miyagahara Tsukasa, Fujita Toshihiro, Fukuchi Satoshi, Takahashi Kosuke, Taguchi Hiroki, Araki Norimasa, Ohtsuka Yuichiro, Uekitani Toshiyuki, Tsuneyoshi Kengo, Akiyama Takumi, Ishigaki Noriko, Maruo Toru, Saito Hirokazu, Ihara Ryo, Yamasuji Akihiro, Oe Shinji, Yoshinari Motohiro, Sagami Ryota, Fujimori Nao, Fukuda Yoshio, Ozawa Eisuke, Jikuya Kenichi, Shinohara Hiroki, Sen-Yo Manabu, Ueki Toshiharu, Tsuchiya Naoaki, Kitaguchi Takanori, Matsumoto Keisuke, Fukuyama Makoto, Hirai Fumihito
Аннотация
METHODS: This multicenter retrospective study was conducted at 22 centers that introduced EUS-BD between 2017 and 2022. A maximum of 20 initial EUS-BD cases at each center were evaluated. The clinical outcomes and experience of 84 endoscopists who performed these procedures were examined. Primary outcomes were the rate of technical success and adverse events (AEs), whereas secondary outcomes were risk factors associated with technical failure and procedure-related AEs.
RESULTS: Two hundred fifty-five patients were enrolled. The technical success rate was 91.4% (233/255). Among 22 technical failure cases, guidewire manipulation failure was the most common cause (n = 12) followed by tract dilation failure (n = 5). The AE rate was 10.2% (26/255). Multivariate analysis identified a puncture target diameter of <5 mm (odds ratio, 3.719; 95% CI, 1.415-9.776; P = .008) and moderate ascites extending to the liver surface (odds ratio, 3.25; 95% CI, 1.195-8.653; P = .021) as independent risk factors for technical failure and procedure-related AEs, respectively. Endoscopists' procedural experience was not a risk factor for technical failure or procedure-related AEs.
CONCLUSIONS: The feasibility and safety of EUS-BD were maintained during the induction phase at inexperienced centers. These data will be helpful to better understand the current status of EUS-BD. (Clinical trial registration number: UMIN 000053615.).